Adjuvant chemotherapy in pancreatic cancer at different AJCC stages: a propensity score matching analysis

ConclusionsThe administration of adjuvant chemotherapy has been shown to improve the prognosis of patients diagnosed with stage I and II pancreatic cancer. However, its efficacy is limited in individuals with stage III pancreatic cancer. Therefore, there is an urgent need to investigate and develop more effective therapeutic options for patients in the advanced stage.
Source: European Journal of Medical Research - Category: Research Source Type: research